Investigation into the hepatotoxicity of the novel anti-cancer drug Ecteinascidin-743 (ET-743)
Ecteinascidin-743 (ET-743) is a novel marine-derived anti-cancer drug with demonstrated anti-tumour activity in clinical trials against sarcoma, breast and ovarian carcinoma. Reversible transaminitis and subclinical cholangitis have frequently been described in patients who receive ET-743. To facili...
| Main Author: | |
|---|---|
| Published: |
University of Leicester
2003
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.490756 |